Are Racial Disparities in Acute Myeloid Leukemia (AML) Clinical Trial Enrollment Associated with Comorbidities and/or Organ Dysfunction?

被引:1
|
作者
Statler, Abby [1 ]
Hobbs, Brian P. [2 ]
Radivoyevitch, Tomas [3 ,4 ]
Mukherjee, Sudipto [5 ]
Bell, Kimberly [6 ]
Advani, Anjali S. [5 ]
Gerds, Aaron T. [5 ]
Nazha, Aziz [5 ]
Patel, Bhumika J. [5 ]
Carraway, Hetty E. [5 ]
Sekeres, Mikkael A. [5 ]
机构
[1] Cleveland Clin, Canc Biostatist, Shaker Hts, OH USA
[2] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH USA
[3] Dept Quantitat Hlth Sci, Cleveland, OH USA
[4] Dept Translat Hematol & Oncol Res, Cleveland, OH USA
[5] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Leukemia Program, Cleveland, OH USA
[6] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH USA
关键词
D O I
10.1182/blood-2019-129096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
381
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Disparities in pediatric acute myeloid leukemia (AML) clinical trial enrollment
    Winestone, Lena E.
    Getz, Kelly D.
    Rao, Pooja
    Li, Yimei
    Hall, Matt
    Huang, Yuan-Shung V.
    Seif, Alix E.
    Fisher, Brian T.
    Aplenc, Richard
    LEUKEMIA & LYMPHOMA, 2019, 60 (09) : 2190 - 2198
  • [2] Racial and ethnic enrollment disparities in acute myeloid leukemia clinical trials.
    Hantel, Andrew
    DeAngelo, Daniel J.
    Luskin, Marlise Rachael
    Garcia, Jacqueline Suen
    Abel, Gregory A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] The Impact of Comorbidities and Organ Dysfunction Commonly Used for Clinical Trial Eligibility Criteria on Outcome in Acute Myeloid Leukemia (AML) Patients Receiving Induction Chemotherapy
    Statler, Abby
    Hobbs, Brian P.
    Radivoyevitch, Tomas
    Siebenaller, Caitlin
    Mukherjee, Sudipto
    Advani, Anjali S.
    Gerds, Aaron T.
    Nazha, Aziz
    Patel, Bhumika J.
    Carraway, Hetty E.
    Sekeres, Mikkael A.
    BLOOD, 2019, 134
  • [4] Acute Myeloid Leukemia (AML) Hospitalizations: Racial Disparity in Outcomes of Patients with Comorbidities
    Alam, Sara Taveras
    Dongarwar, Deepa
    Lopez, Elyse
    Yellapragada, Sarvari Venkata
    Rivero, Gustavo
    Miller-Chism, Courtney Nicole
    Mims, Martha P.
    Huang, Quillan
    Salihu, Hamisu
    BLOOD, 2021, 138
  • [5] Survival Disparities By Frontline Clinical Trial Enrollment Status for Treatment of Pediatric Acute Myeloid Leukemia
    Zheng, Daniel J.
    van der Mei, Elsa
    Li, Yimei
    Huang, Yuan-Shung V.
    Aftandilian, Catherine
    Bona, Kira
    Caywood, Emi
    Collier, Anderson B.
    Gramatges, M. Monica
    Heneghan, Mallorie M.
    Henry, Meret
    Lotterman, Craig
    Maloney, Kelly
    Miller, Tamara P.
    Modi, Arunkumar
    Mody, Rajen
    Morgan, Elaine
    Winick, Naomi J.
    Wilkes, Jennifer J.
    Wong, Victor
    Newman, Haley
    Myers, Regina M.
    Elgarten, Caitlin W.
    Seif, Alix E.
    Fisher, Brian T.
    Aplenc, Richard
    Getz, Kelly D.
    BLOOD, 2023, 142
  • [6] Racial Disparities in Inpatient Outcomes for Patients Admitted with Acute Myeloid Leukemia (AML)
    Khan, Fayaz
    Rahima, Kenan
    Singeltary, Brian Patrick
    Zamani, Taraneh
    Durhman, Madelyn
    Jose, Thulasee
    BLOOD, 2024, 144 : 2433 - 2434
  • [7] Eliminating racial disparities associated with clinical trial enrollment in gynecologic oncology patients
    Boitano, Teresa
    Gentry, Zachary
    Leath, Charles
    Straughn, J. Michael
    Smith, Haller
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S218 - S218
  • [8] Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials
    Hantel, Andrew
    Luskin, Marlise R.
    Garcia, Jacqueline S.
    Stock, Wendy
    DeAngelo, Daniel J.
    Abel, Gregory A.
    BLOOD ADVANCES, 2021, 5 (21) : 4352 - 4360
  • [9] Racial and ethnic disparities in the survival of adolescents and young adults (AYA) with acute myeloid leukemia (AML)
    Durani, Urshila
    Bartley, Adam C.
    Go, Ronald S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [10] Identifying eligibility criteria that perpetuate race/ethnic disparities in acute myeloid leukemia (AML) clinical trial participation
    Hantel, Andrew
    Wang, Yating
    Abraham, Ivy
    Patel, Anand Ashwin
    Monick, Sarah Elizabeth
    Rauscher, Garth H.
    Rodriguez, Ana Maria Avila
    Galvez, Carlos
    Doukas, Peter
    Altman, Jessica K.
    Burkart, Madelyn
    Erra, Amani
    Zia, Maryam
    Larson, Melissa L.
    Dave, Ami Atulkumar
    Tsai, Stephanie
    Aleem, Ahmed
    Raptis, Nepheli
    Khan, Irum
    Abel, Gregory A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)